Biomerica (NASDAQ:BMRA) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

Biomerica, Inc. (NASDAQ:BMRA)’s share price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.44 and traded as high as $0.72. Biomerica shares last traded at $0.71, with a volume of 309,461 shares trading hands.

Biomerica Trading Down 3.5 %

The firm has a 50-day moving average of $0.65 and a 200 day moving average of $0.44. The company has a market cap of $12.56 million, a P/E ratio of -2.02 and a beta of -1.16.

Biomerica (NASDAQ:BMRA) last issued its quarterly earnings data on Tuesday, January 14th. The company reported ($0.06) EPS for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Institutional Trading of Biomerica

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC lifted its holdings in shares of Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 658,767 shares of the company’s stock after acquiring an additional 131,306 shares during the quarter. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 at the end of the most recent quarter. 22.28% of the stock is currently owned by hedge funds and other institutional investors.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.